Entrada Therapeutics Statistics
Total Valuation
TRDA has a market cap or net worth of $433.12 million. The enterprise value is $145.43 million.
| Market Cap | 433.12M |
| Enterprise Value | 145.43M |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, before market open.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TRDA has 33.60 million shares outstanding. The number of shares has increased by 5.61% in one year.
| Shares Outstanding | 33.60M |
| Shares Change (YoY) | +5.61% |
| Shares Change (QoQ) | -15.65% |
| Owned by Insiders (%) | 15.46% |
| Owned by Institutions (%) | 78.74% |
| Float | 13.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.36 |
| Forward PS | 6.86 |
| PB Ratio | 1.79 |
| P/FCF Ratio | 3.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.76, with an EV/FCF ratio of 1.08.
| EV / Earnings | n/a |
| EV / Sales | 1.13 |
| EV / EBITDA | 9.76 |
| EV / EBIT | 12.06 |
| EV / FCF | 1.08 |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.28.
| Current Ratio | 2.33 |
| Quick Ratio | 2.28 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 4.58 |
| Debt / FCF | 0.51 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -2.90%.
| Return on Equity (ROE) | -2.90% |
| Return on Assets (ROA) | -1.40% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $811,403 |
| Profits Per Employee | -$42,044 |
| Employee Count | 159 |
| Asset Turnover | 0.27 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TRDA has paid $18.74 million in taxes.
| Income Tax | 18.74M |
| Effective Tax Rate | 155.45% |
Stock Price Statistics
The stock price has decreased by -8.32% in the last 52 weeks. The beta is -0.50, so TRDA's price volatility has been lower than the market average.
| Beta (1Y) | -0.50 |
| 52-Week Price Change | -8.32% |
| 50-Day Moving Average | 13.23 |
| 200-Day Moving Average | 14.73 |
| Relative Strength Index (RSI) | 48.30 |
| Average Volume (30 Days) | 77,048 |
Short Selling Information
The latest short interest is 1.77 million, so 5.26% of the outstanding shares have been sold short.
| Short Interest | 1.77M |
| Short Previous Month | 1.79M |
| Short % of Shares Out | 5.26% |
| Short % of Float | 13.02% |
| Short Ratio (days to cover) | 21.22 |
Income Statement
In the last 12 months, TRDA had revenue of $129.01 million and -$6.69 million in losses. Loss per share was -$0.20.
| Revenue | 129.01M |
| Gross Profit | 129.01M |
| Operating Income | -3.16M |
| Pretax Income | 12.06M |
| Net Income | -6.69M |
| EBITDA | 14.90M |
| EBIT | 12.06M |
| Loss Per Share | -$0.20 |
Balance Sheet
The company has $355.92 million in cash and $68.23 million in debt, giving a net cash position of $287.69 million or $8.56 per share.
| Cash & Cash Equivalents | 355.92M |
| Total Debt | 68.23M |
| Net Cash | 287.69M |
| Net Cash Per Share | $8.56 |
| Equity / Book Value | 242.36M |
| Book Value Per Share | 7.21 |
| Working Capital | 210.98M |
Cash Flow
In the last 12 months, operating cash flow was $139.80 million and capital expenditures -$5.61 million, giving a free cash flow of $134.19 million.
| Operating Cash Flow | 139.80M |
| Capital Expenditures | -5.61M |
| Free Cash Flow | 134.19M |
| FCF Per Share | $4.06 |
Margins
Gross margin is 100.00%, with operating and profit margins of -2.45% and -5.18%.
| Gross Margin | 100.00% |
| Operating Margin | -2.45% |
| Pretax Margin | 9.34% |
| Profit Margin | -5.18% |
| EBITDA Margin | 11.55% |
| EBIT Margin | 9.34% |
| FCF Margin | 104.01% |
Dividends & Yields
TRDA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.61% |
| Shareholder Yield | -5.61% |
| Earnings Yield | -1.54% |
| FCF Yield | 30.98% |
Analyst Forecast
The average price target for TRDA is $21.00, which is 62.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.00 |
| Price Target Difference | 62.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TRDA has an Altman Z-Score of 1.46 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.46 |
| Piotroski F-Score | 2 |